Back to top
more

Tandem Diabetes Care (TNDM)

(Delayed Data from NSDQ)

$15.40 USD

15.40
1,385,256

-0.18 (-1.16%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $15.39 -0.01 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Options Traders Expect Huge Moves in Tandem Diabetes Care (TNDM) Stock

by Zacks Equity Research

Tandem Diabetes Care (TNDM) needs investors to pay close attention to the stock based on moves in the options market lately.

    Zacks Equity Research

    5 Health Care ETFs Outperforming XLV on YTD Basis

    by Zacks Equity Research

    Health care ETFs provide handsome returns year to date.

      Zacks Equity Research

      Is the Options Market Predicting a Spike in Tandem Diabetes (TNDM) Stock?

      by Zacks Equity Research

      Investors need to pay close attention Tandem Diabetes (TNDM) stock based on the movements in the options market lately.

        Zacks Equity Research

        Company News For Jun 25, 2018

        by Zacks Equity Research

        Companies In The News are: RHT,BB,KMX,TNDM

          Zacks Equity Research

          Options Traders Expect Huge Moves in Tandem Diabetes Care (TNDM) Stock

          by Zacks Equity Research

          Investors in Tandem Diabetes Care (TNDM) need to pay close attention to the stock based on moves in the options market lately.

            Zacks Equity Research

            Tandem Diabetes Care (TNDM): Moving Average Crossover Alert

            by Zacks Equity Research

            Tandem Diabetes Care, Inc. (TNDM) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front

              Zacks Equity Research

              The Zacks Analyst Blog Highlights: Tandem Diabetes Care, Addus HomeCare, Tailored Brands, Tellurian and Johnson & Johnson

              by Zacks Equity Research

              The Zacks Analyst Blog Highlights: Tandem Diabetes Care, Addus HomeCare, Tailored Brands, Tellurian and Johnson & Johnson

                Tirthankar Chakraborty headshot

                Wall Street Brushes Off Trade War Fears: Top 5 Gainers

                by Tirthankar Chakraborty

                The Dow climbed more than 700 points after investors downplayed fears over tariffs announced by both China and the United States.

                  Zacks Equity Research

                  Tandem Diabetes Care (TNDM) Shares March Higher, Can It Continue?

                  by Zacks Equity Research

                  As of late, it has definitely been a great time to be an investor in Tandem Diabetes Care, Inc. (TNDM)

                    Zacks Equity Research

                    New Year to Bring Back MedTech Tax, 3 Stocks Unfazed

                    by Zacks Equity Research

                    Investors are apprehensive about the re-enactment of MedTech Tax and related concerns, despite raking in returns from other sectors.

                      Zacks Equity Research

                      The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT

                      by Zacks Equity Research

                      The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT

                        Zacks Equity Research

                        5 MedTech Stocks for Stellar Returns in Q3

                        by Zacks Equity Research

                        Here we take a sneak peek into two burning issues that are likely to impact the quarterly numbers in the MedTech fraternity.

                          Zacks Equity Research

                          4 Top Growth Picks as MedTech Battle Rages On

                          by Zacks Equity Research

                          Trump's Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.

                            Zacks Equity Research

                            The Saga to Revoke Obamacare Continues: 3 MedTech Picks

                            by Zacks Equity Research

                            In the wake of the turbulent political scenario and banking on favorable metrics, these three MedTech stocks stand out as the most suitable picks.

                              Zacks Equity Research

                              Implied Volatility Surging for Tandem (TNDM) Stock Options

                              by Zacks Equity Research

                              Tandem (TNDM) warrants investors' attention based on moves in the options market lately.

                                Zacks Equity Research

                                3 Med-Instrument Stocks Poised to Gain this Earnings Season

                                by Zacks Equity Research

                                2015 is forecasted to be a transition year for the medical instruments sector.